Revivegen Co (7578) Fair Value & Analysis
Industrials · TW · Market cap 1.7B TWD
Fair value as of: Jul 21, 2026
From 9 valuation models · updated 20 days ago
Share price −15.0% over the past month.
Below-average quality, and screening another 70% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (10.28 TWD). The favourable scenario is already priced in.
- Weak quality (25/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (5.54 TWD to 10.28 TWD) leaves room in how you read the outcome.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
50‑month range 26.05 TWD – 50.44 TWD · fair‑value band 5.54 TWD – 10.28 TWD · the 26.10 TWD price screens above the 7.91 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Revivegen Co (7578) currently trades at 26.10 TWD, while our model-based Fair Value estimate is 7.91 TWD, implying the stock looks roughly 69.7% overvalued today. The Quality Score stands at 25/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Revivegen Co generated revenue of 469M TWD at a net margin of 4.3%. Revenue grew 11.3% year over year. It earns a return on equity of 0.9%. Net debt stands at 3.2B TWD. Fundamentals as of Jul 21, 2026
Our scenario range runs from 5.54 TWD (bear case) to 10.28 TWD (bull case); at 26.10 TWD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 46% below its 52-week high, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -40% fair-value upside, at -70%, 7578 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 9 models by family
Widest divergence: Asset-Based (16.77 TWD) versus Earnings-Based (5.34 TWD). Highest evidence: Residual Income (76).
Notify me when 7578 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 27 · Market factors (momentum, volatility) 31
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Revivegen Co., Ltd. engages in the industrial waste treatment business in Taiwan. It is involved in the waste solvent physical treatment and thermal treatment activities; and provision of semiconductor cleaning agent, chip cleaning agent, paint and coating additives, and lithium battery auxiliary materials. Revivegen Co., Ltd.
Full company description
Revivegen Co., Ltd. engages in the industrial waste treatment business in Taiwan. It is involved in the waste solvent physical treatment and thermal treatment activities; and provision of semiconductor cleaning agent, chip cleaning agent, paint and coating additives, and lithium battery auxiliary materials. Revivegen Co., Ltd. was founded in 2010 and is headquartered in Tainan City, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Revivegen Co reported revenue of 469M TWD in FY2025 versus 337M TWD in FY2021, a compound +8.6%/yr. Reported net income was 20.4M TWD in FY2025, compounding −13.0%/yr from FY2021.
7578 screens 70% overvalued. Compare with Waste Management, Inc →
Peer Group
Waste Management · 166 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Waste Management median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Waste Management stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Waste Management, Inc WM | $233.33 | $128.02 | -45% |
| Republic Services, Inc RSG | $219.20 | $122.01 | -44% |
| Waste Connections, Inc WCN | C$242.43 | C$78.67 | -68% |
| Veolia Environnement SA VIE | €37.51 | €24.50 | -35% |
| Clean Harbors, Inc CLH | $303.64 | $155.37 | -49% |
| GFL Environmental Inc GFL | C$55.40 | C$94.12 | +70% |
| Fomento de Construcciones y Contratas, S.A FCC | €12.20 | €7.30 | -40% |
| GEM Co 002340 | ¥6.32 | ¥5.27 | -17% |
| Zhejiang Weiming Environment Protection Co 603568 | ¥16.18 | ¥20.91 | +29% |
| Cleanaway Waste Management Limited CWY | A$2.34 | A$1.18 | -50% |
Compare Revivegen Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Revivegen Co (7578) overvalued or undervalued?
What is the fair value of 7578?
What is the quality score of 7578?
What is the revenue of Revivegen Co (7578)?
What is the net profit margin of 7578?
Does Revivegen Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Revivegen Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.